Systematic Assessment of Dysexecutive Syndrome, Hypersomnolence and Dysautonomia in Kleine‐Levin Syndrome
European Journal of Neurology · 2025
DOI: 10.1111/ene.70259 ↗At a glance
Journal article in European Journal of Neurology, 2025. Written by Lucie Barateau and 6 co-authors. Institution: Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, Montpellier, France. Major MEDLINE topics: Kleine-Levin Syndrome, Primary Dysautonomias, Disorders of Excessive Somnolence, Executive Function. Cited 2 times so far (Crossref); 32 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Background
Kleine‐Levin Syndrome (KLS) is a neurological disorder of unknown pathophysiology. It is characterized by relapsing–remitting episodes of hypersomnia, with cognitive symptoms and behavioral disturbances. The diagnosis relies on clinical criteria, which require further standardization. Our main objective was to better phenotype and systematically quantify the severity and impact of cognitive and behavioral symptoms, hypersomnolence and dysautonomia in a well‐characterized population of KLS patients.
Methods
Forty‐three consecutive KLS patients diagnosed in a National Reference Center for Rare Hypersomnias underwent a standardized clinical and polysomnographic evaluation and completed validated questionnaires with their relatives. The Behavioral Dysexecutive Syndrome Inventory (BDSI) assessed their behavior during most episodes. The Idiopathic‐Hypersomnia Severity Scale (IHSS) assessed different hypersomnolence components (inertia, sleepiness, prolonged sleep), and the Scale for Outcomes in Parkinson's Disease‐Autonomic (SCOPA‐AUT) assessed dysautonomia. The latter two scales were completed twice to differentiate symptoms during and between episodes.
Results
During symptomatic periods, behavioral changes were observed in all BDSI domains, more than half of patients showing reduced activities and apathy, anticipation–organization–initiation difficulties, disinterest, irritability–aggression, perseveration–stereotypies, and sexual or eating disorders. IHSS scores were severe and higher during episodes (42.6 ± 5.8 vs. 15.6 ± 9.8, p < 0.0001), and each item higher. The SCOPA‐AUT scores were higher during episodes (12.1 ± 8.5 vs. 8.5 ± 8.2, p = 0.0001), particularly in the cardiovascular, pupillomotor, and thermoregulation domains.
Conclusions
Our findings suggest the relevance of the BDSI for the evaluation of dysexecutive behavioral symptoms in KLS. The IHSS would be useful for phenotyping hypersomnolence and the SCOPA‐AUT for assessing dysautonomia during episodes. Future studies could combine the BDSI with imaging and other biomarkers to explore the neuroanatomical correlates of this enigmatic disorder.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Sleep-Wake Disorders Unit, Department of Neurology, Gui-de-Chauliac Hospital, CHU Montpellier, Montpellier, France.
- National Reference Centre for Orphan Diseases, Narcolepsy, Idiopathic Hypersomnia, and Kleine-Levin Syndrome, Montpellier, France.
- Institute of Neurosciences of Montpellier, University of Montpellier, INSERM, Montpellier, France.
Cite
APA
Barateau, L., Diab, J., Thobois, O., Chenini, S., Béziat, S., Jaussent, I., & Dauvilliers, Y. (2025). Systematic Assessment of Dysexecutive Syndrome, Hypersomnolence and Dysautonomia in Kleine‐Levin Syndrome. European Journal of Neurology. https://doi.org/10.1111/ene.70259
Vancouver
Barateau L, Diab J, Thobois O, Chenini S, Béziat S, Jaussent I, et al. Systematic Assessment of Dysexecutive Syndrome, Hypersomnolence and Dysautonomia in Kleine‐Levin Syndrome. European Journal of Neurology. 2025. doi:10.1111/ene.70259
BibTeX
@article{Barateau2025,
author = {Barateau, Lucie and Diab, Joseph and Thobois, Ophélie and Chenini, Sofiene and Béziat, Séverine and Jaussent, Isabelle and Dauvilliers, Yves},
title = {Systematic Assessment of Dysexecutive Syndrome, Hypersomnolence and Dysautonomia in Kleine‐Levin Syndrome},
journal = {European Journal of Neurology},
year = {2025},
doi = {10.1111/ene.70259}
}
EUVIMED